Simple Pharma
Caroline Escolier is an experienced professional in operations and project management, currently serving as the Head of Operations and Quality at The Simple Pharma Company since January 2020, overseeing key areas such as supply chain, customer service, and logistics. Prior to this role, Caroline held various positions, including Associate Project Manager, focusing on supply chain planning and tech transfers, and Founder of CASSIOPEE Solucions, which provided project management and administrative outsourcing services. Additional experience includes CEO of Assegurances Generals, where responsibility encompassed commercial strategy and operational management, and several roles at AXA France, ranging from Customer Service Manager to IT Project Manager, specializing in wealth management and insurance solutions. Caroline holds a Master’s degree in Management des Systèmes d’Information from Université Paris Dauphine - PSL and a DESS from Université Grenoble I.
This person is not in any teams
This person is not in any offices
Simple Pharma
Simple Pharma is the best home for proven pharma products. We provide integrated, digitally enabled, end to end operations, distribution, and compliance services to pharma companies. We’re passionate about simplifying the complex world of pharma operations to enable better access to medicines on a global scale. Simple Pharma is re-thinking the traditional sales-led model of the pharma industry by focusing on razor-sharp operations. By lowering unit costs, using software to automate repeatable processes, and increasing the overall agility of the system we can allow products to reach the market faster and cheaper, and stay on the market for longer. We can do that independently of who the product owner is, selling the platform as a service to, for example, U.S. innovators who want to launch globally, or financial operators who own a portfolio of assets. We think that delivering on the vision of 'platform pharma as a service' will enable commercial entities to focus on launching and promoting medicines without needing to worry about building pharma backbone capabilities. By being the go-to partner for pharma companies looking to divest products or outsource their operations, we believe we can fundamentally improve patient access to medicines on a global scale. Simple Pharma currently operates two global products in 20+ markets. Our team of ~15 superstars are based across 5 countries. www.simplepharma.com